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universally beneficial for patients with this syndrome. We ought to 
remember that the term "syndrome X" is a descriptive t rm only, and 
a poor one indeed. Syndrome X is a heterogeneous entity, and 
different patient subgroups have now been identified. In some patients, 
symptoms may be caused by myocardial ischemia or microvascular 
endothelial dysfunction, or both; in others by increased pain percep- 
tion, estrogen deficiency, psychologic disturbances or a combination of 
these. Patients with insulin resistance may represent another pathoge- 
netic subgroup. However, the proportion of patients with syndrome X
in whom insulin resistance isresponsible for the clinical manifestations 
is not yet known. 
A trial of metabolic therapy, as suggested by Seery, may be 
justifiable in syndrome X. However, this approach is likely to succeed 
in only those patients whose symptoms are caused by the metabolic 
disorder but not in every patient with angina and normal coronary 
arteriographic findings. Too often since the initial description of 
syndrome X have investigators mistakingly attempted to identify a 
single etiologic mechanism for this heterogeneous condition. Let us 
not fall into this trap yet again. 
JUAN CARLOS KASKI, MD, FACC, FESC 
Coronary Artery Disease Research Group 
St. George's Hospital Medical School 
Cranmer Terrace 
London SWI7 ORE, England, United Kingdom 
References 
1. Opherk D, Zebe H, Weihe E, et al. Reduced coronary dilatory capacity and ultrastructura/ 
changes of the myocardium in patients with angina pectoris but normal coronary arterio- 
grams. Circulation 1981;63:817 25. 
2. Cannon RO, Camici PG, Epstein SE. Pathnphysiolugical dilemma of syndrome X. 
Circulation 1992;85:883-92. 
3. Egashira K, lnou T, Hirooka Y, Yamada A~ Urabe Y, Takeshita A. Evidence of impaired 
endothelium-dependcnt coronary, vasudilatatkm in patients with angina pectoris and 
normal coronary arteriograms. N Engl J Med 1993~328:1659-64. 
4. Rosen SD, Uren NG, Kaski JC, Tousoulis D, Davies GJ~ Camici PG. Coronal3' vasodilator 
reserve, pain perception and sex in patients with syndrome X. Circulation 1994;90:50-6(I. 
5. Cannon RO, Ouyyumi AA, Mincemoyer R, et al. lmipramine in patients with chest pain 
despite normal coronary angiograms. N Engl J Med 1994;330:1411-7. 
6. Rosano GMC, Ponikowski P,Adamopoulos S. el al. Abnormal autonomic control of the 
cardiovascular system in syndrome X. Am J Cardiol 199453:11744. 
7. Kaski JC, Rosario G, Gavrielides S, Chen L. Effects of angiotensin-converting inhibition on 
exercise-induced angina nd ST segment depression i  patients with microvascular angina. 
J Am Coil Cardiol 1994;23:652-7. 
8. Betker HE, Moiler N, Ovensen P, et al. Insulin rcsistance in microvascular ngina 
(syndrome X). Lancet 1993;342:136-40. 
Assessment of Cardiovascular 
Autonomic Function 
I read the report by Zarich et al. (1) with immense interest. However, 
I am concerned about the methodology, used in testing the autonomic 
function of their patients. The cutoff points for an "abnormal" test 
result for the Valsalva maneuver and the systolic blood pressure 
response to standing were taken as 1.25 and 20 mm Hg, respectively. In 
fact, these should be 1.10 for the Valsalva maneuver and 30 mm Hg for 
a decrease in systolic blood pressure (2). Zarich et al. did not take into 
consideration the heart rate response to standing, which tests the 
parasympathetic autonomic nervous ystem. The involvement of the 
parasympathetic autonomic nervous ystem is inferred by Zarich et al. 
to be more involved in diabetic autonomic neuropathy, causing the 
circadian pattern of myocardial isehemia. Again, the autonomic score 
is given as 0, 1 or 2, depending on whether a test result is normal, 
borderline or abnormal (3). A "battery" of at least five autonomic tests 
should be performed rather than the four used by Zarich et al. because 
no single test is sensitive enough to detect and classify types of 
autonomic dysfunction (3). Despite the battery of five autonomic tests, 
-6% of patients with autonomic insufficiency are unclassifiable and 
are grouped as "atypical" (2,3). I note that the Valsalva maneuver was 
performed only once, whereas a mean of three successive maneuvers i  
recommended (4). Such tests would stratify patients differently, and 
the differences in circadian patterns of ambulatory myocardial isch- 
emia between groups I and II in the Zarich et al. study might therefore 
not hold true. 
The frequency of silent myocardial ischemia in patients with 
autonomic insufficiency may be explained by a higher pain sensitivity 
threshold and ischemia tolerance in diabetic patients with autonomic 
neuropathy (5,6). In experimental nimals, a "denervation supersen- 
sitivity," causing enhanced sensitivity to the action of the sympathetic 
nervous ystem may occur (7). Pericardial prostaglandins released in 
the pericardial fluid, modulating the sympathetic effects of the heart, is 
an interesting hypothesis (7). Myocardial ischemia s the cause rather 
than the effect of neuropathy, including autonomic neuropathy, par- 
ticularly in early myocardial ischemia, is an exciting new concept and 
requires further confirmation (8,9). 
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Reply 
Siddiqui asserts that there is one battery of cardiovascular tests of the 
autonomic nervous ystem with universally accepted cutoffs between 
normal and abnormal test results. In reality, there are a number of 
different ests assessing cardiovascular utonomic function and no 
single established battery (1-3). Any test used to assess cardiovascular 
autonomic function should have acceptable sensitivity, specificity and 
reproducibility. Some investigators (2-4) have reported, for example, 
that the heart rate response to standing, a test advocated by Siddiqui, 
does not fulfill these criteria. The four tests that we used in our study 
to measure autonomic function satisfy the sensitivity, specificity and 
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reproducibility criteria and provide an accurate and reliable measure 
of sympathetic and parasympathetic nervous ystem function (3,4). 
However, there is general agreement with respect to the derivation 
of reference values for the tests of autonomic function. Autonomic test 
results are dependent on a number of variables that include patient age 
and laboratory test technique. It is therefore ssential that clinical and 
research autonomic laboratories establish their own age-based refer- 
ence values using standard statistical techniques and not merely use 
normal values derived from published reports, as suggested by Siddiqui 
(3-5). 
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Integrated Doppler Backscatter Power 
We read with interest he recent report by MacIsaac et al. (1). The 
theoretic background used in this report requires ome clarification. 
We agree that the power of the Doppler signal is proportional to the 
volume of insonated blood in motion. This relation is also known as the 
zeroth moment of the Doppler spectrum (2). In contrast, blood volume 
flow is proportional to the first moment of the Doppler spectrum, 
which represents the integrated sum of the product of Doppler 
backscatter power multiplied by the velocity of the corresponding 
scattering particles (2). Quantification of mitral regurgitation requires 
the calculation of total and forward stroke volumes. Total stroke 
volume is assessed from the first moment of the Doppler spectrum of 
the mitral inflow, whereas forward stroke volume results from the first 
moment of the Doppler spectrum of the left ventricular outflow tract. 
In the study by MacIsaac et al., total stroke volume as well as forward 
stroke volume were derived from the zeroth moment of the Doppler 
spectrum on the basis of the false assumption that "the volume of 
blood in motion has a constant relation to the volume of flow and that 
integrating the Doppler backscatter power over the duration of flow 
will provide a result proportional to the volume of blood flowing across 
the valve" (1). 
Moreover, we were surprised that the issue of adequacy of beam 
width of the Doppler beam was not addressed at all by MacIsaac et al. 
in their report. According to our experience (3), the width of the 
continuous wave Doppler beam, depending on the equipment used, 
might often be considerably ess than the cross section of the interro- 
gated annulus. This is true for most commercially available continuous 
wave Doppler systems. 
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Use of Backscattered Doppler Signal 
Intensity in Estimation of Volume 
Flow Ratios 
Maclsaac et al. (1) propose an interesting new method for assessing 
mitral regurgitation using the power of the backscattered Doppler 
signal. Central to this approach is the theory that the Doppler signal 
intensity is proportional to the flow volume insonated. However, to 
apply the theory to flow across a valve annulus, two conditions must be 
met: 1) The depth of flow measurement must be restricted to the level 
of the annulus; and 2) the full cross-sectional rea of flow must be 
insonated by the Doppler beam. Five studies have been reported (1-5), 
including the recent investigation by MacIsaac et al., that estimate flow 
ratios using backscattered signal intensity using continuous wave 
Doppler. Unfortunately, continuous wave Doppler satisfies neither of 
the two previous conditions. 
1) The depth of flow measurement must be restricted to the level of the 
annulus, The continuous wave Doppler samples flow along the entire 
length of the Doppler beam. If the continuous wave Doppler beam is 
placed in the mitral annulus from the apical window to evaluate mitral 
inflow, for example, one would also be gathering information about 
pulmonary venous inflow as well as flow within the left ventricle during 
diastole, Not only is flow sampled at multiple sites simultaneously, but 
also the same volume of blood will be insonated more than once 
depending on how long the sample remains within the Doppler beam. 
Thus, the same volume of blood may be counted multiple times 
throughout the time of volume flow evaluation. (Idealized in vitro 
studies were able to overcome these limitations by interrogating flow 
through tubes at an angle [6-13]. In this manner, the continuous wave 
beam insonated the cross-sectional area of flow at one site in the tube 
only.) 
2) The full cross-sectional rea of flow must be insonated by the 
Doppler beam. When the mitral valve annulus or aortic annulus is 
interrogated from the apical window, only a small portion of the flow 
